Cancer risks in rheumatoid arthritis patients who received immunosuppressive therapies: Will immunosuppressants work?

Cancer risks in rheumatoid arthritis patients who received immunosuppressive therapies: Will immunosuppressants work?

BackgroundExploring the cancer risks of rheumatoid arthritis (RA) patients with disease-modifying anti-rheumatic drugs (DMARDs) can help detect, evaluate, and treat malignancies at an early stage for these patients. Thus, a comprehensive analysis was conducted to determine the cancer risk of RA pati...

Full description

Bibliographic Details
Main Authors: Yuzhuo Zhang, Jiangpeng Lin, Zhixuan You, Hengjia Tu, Peng He, Jiarong Li, Rui Gao, Ziyu Liu, Zhiyuan Xi, Zekun Li, Yi Lu, Qiyuan Hu, Chenhui Li, Fan Ge, Zhenyu Huo, Guibin Qiao
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-12-01
Series:Frontiers in Immunology
Subjects:
rheumatoid arthritis
cancer risk
immunosuppression therapy
immunosuppressant
tumor mutational burden
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2022.1050876/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2022.1050876/full

Similar Items